Skip to content

AcrySof™ IQ Vivity™ DFT515 (REF DFT515.215)Recalls & reported problems

Alcon Laboratories, Inc. · Sterile UV and Blue Light Filtering Acrylic Foldable Aspheric Wavefront-Shaping Toric Posterior Chamber Intraocular Lenses · Class 3 · Implant

Adverse event reports
3
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00380652422499), received between Dec 24, 2021 and Apr 12, 2023 — classified as 2 injuries, 1 malfunction.

The most frequently reported specific device problem is “Scratched Material” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Scratched Material1

Patient problems

  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
  • Blurred Vision1
  • Insufficient Information1
  • Visual Disturbances1
  • Visual Impairment1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 12, 2023Scratched Material; Scratched Material

    A PHYSICIAN REPORTED THAT DURING A CATARACT EXTRACTION WITH AN INTRAOCULAR LENS IOL IMPLANT PROCEDURE, LENS MARK WAS NOTICED ON IMPLANTATION. ADDITIONAL INFORMATION WAS REQUESTED, BUT FURTHER NO INFORMATION WAS AVAILABLE.

    Patient problems: Insufficient Information

    MAUDE report 16723897 ↗
  • InjuryJan 4, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A HEALTHCARE PROFESSIONAL REPORTED 2-3 MONTHS FOLLOWING AN INTRAOCULAR LENS IMPLANT PROCEDURE, THE PATIENT WAS UNABLE TO ACHIEVE VISUAL ACUITY BETTER THAN 6/36, POOR VISUAL ACUITY AT ALL DISTANCES. THE PATIENT WAS BOOKED FOR EXPLANTATION OF THE LENS AT (B)(6) 2021. ADDITIONAL INFORMATION WAS RECEIVED WHICH STATES THE SAMPLE HAS BEEN RETURNED INDICATING THE LENS EXCHANGE WAS PERFORMED.

    Patient problems: Visual Impairment

    MAUDE report 13150633 ↗
  • InjuryDec 24, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A NON-HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING IMPLANTATION OF AN INTRAOCULAR LENS (IOL), THE PATIENT HAD BLURRY VISION AND GLARE AND VISUAL DISTURBANCE. THE LENS WAS EXCHANGED WITH ANOTHER IOL 9 MONTHS POST INITIAL PROCEDURE. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Blurred Vision; Visual Disturbances

    MAUDE report 13084832 ↗

Other Extended depth of focus intraocular lens devices

All Extended depth of focus intraocular lens devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.